• Policy
• Combination of Forxiga + Januvia was applied for permission
• by Lee, Tak-Sun May 4, 2021 05:55am

• Policy
• Afstyla will be reimbursed from June
• by Kim, Jung-Ju May 4, 2021 05:55am

• Policy
• MFDS, "will make all efforts to pass and land the 1+3 bill"
• by Lee, Jeong-Hwan May 3, 2021 05:54am

• Company
• Hanmi launched a new challenge for patent of Entresto
• by Kim, Jin-Gu May 3, 2021 05:54am

• Company
• Dong-A ST’s Nesp biosimilar export exceeds ₩10 bil.
• by An, Kyung-Jin May 3, 2021 05:53am

• Policy
• The number of COVID-19 vaccinations exceeded 3 million
• by Kim, Jung-Ju May 3, 2021 05:53am

• Company
• Yungjin won patent dispute on Abilify after 6 years
• by Kim, Jin-Gu May 3, 2021 05:53am

• InterView
• "Embrace precision medicine and tumor-agnostic therapy"
• by Eo, Yun-Ho Apr 30, 2021 06:12am

• Company
• SGLT-2 inhibitor combos drive sales in diabetes market
• by Kim, Jin-Gu Apr 30, 2021 06:10am

• Policy
• There is no problem with AZ vaccine safety
• by Kim, Jung-Ju Apr 30, 2021 06:09am